Latest News and Press Releases

魁北克康华, June 23, 2020 (GLOBE NEWSWIRE) -- Altasciences今天宣布任命Joseph A. Francisco博士为首席毒物学家，自2020年6月22日起就任。 ...

LAVAL, Québec, 23 juin 2020 (GLOBE NEWSWIRE) -- Altasciences a annoncé aujourd'hui la nomination du Dr Joseph A. Francisco au poste de toxicologue en chef, à compter du 22 juin 2020. Le Dr...

LAVAL, Quebec, June 22, 2020 (GLOBE NEWSWIRE) -- Altasciences announced today the appointment of Dr. Joseph A. Francisco as Chief Toxicologist, effective June 22, 2020. Dr. Francisco is a...

魁北克拉瓦勒, June 09, 2020 (GLOBE NEWSWIRE) -- Altasciences今天宣布，任命Gaetano Morelli博士为首席医疗官，2020年5月14日起生效。 ...

LAVAL, Quebec, June 09, 2020 (GLOBE NEWSWIRE) -- Altasciences announced today the appointment of Dr. Gaetano Morelli as Chief Medical Officer, effective May 14, 2020. Dr. Morelli is a member of the...

魁北克拉瓦尔, March 28, 2020 (GLOBE NEWSWIRE) --...

LAVAL, Quebec, March 27, 2020 (GLOBE NEWSWIRE) -- Altasciences has completed a Phase I study for the development of gimsilumab, a fully human monoclonal antibody that targets granulocyte-macrophage...

魁北克省拉瓦勒, March 18, 2020 (GLOBE NEWSWIRE) -- 专门从事以灵活创新方式进行全面早期药品开发的美国及加拿大CRO（委托研究机构）Altasciences今天宣布，该机构已与位于中国及美国的转化及咨询临床研究机构Amador Bioscience签署合作协议。这一合作伙伴关系旨在扩大世界级的能力和资源，促进中国和北美的药物研发。 “我们为能与Amador...

LAVAL, Quebec, March 17, 2020 (GLOBE NEWSWIRE) -- Altasciences, a CRO in the U.S. and Canada specializing in a flexible, innovative approach to comprehensive early stage drug development, announced...

魁北克省拉瓦尔, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Altasciences宣布Paul Sidney加入其合规与法规事务团队，担任高级总监。Paul在Charles River Laboratories工作的丰富经验，加上他直接参与各种关键监管计划的经验，使他在药物开发领域的的制药公司、CRO和监管代表中受到高度赞誉。 ...